Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Evolving issues in understanding and treating bacterial vaginosis.

Jeanne M Marrazzo1

  • 1University of Washington, Department of Medicine, Harborview Medical Center, Division of Allergy and Infectious Diseases, 325 Ninth Avenue, Mailbox 359931, Seattle, WA 98104, USA. jmm2@u.washington.edu

Expert Review of Anti-Infective Therapy
|November 30, 2004
PubMed
Summary

Bacterial vaginosis (BV) involves a loss of beneficial Lactobacillus and an overgrowth of anaerobic bacteria. Current antibiotic treatments for BV often lead to recurrence, necessitating novel therapeutic strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccine Treatment and Evaluation Units: Why Support a "Ready Base" of Clinical Trial Sites?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Navigating the path forward for evidence-based management of long COVID.

Nature immunology·2025
Same author

DoxyPEP to Prevent Bacterial STIs-Ready for Prime Time?

JAMA internal medicine·2025
Same author

Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women.

The Journal of infectious diseases·2024
Same author

Uptake and Persistence of Safer Conception Strategies Among South African Women Planning for Pregnancy.

AIDS and behavior·2024
Same author

The Legacies of Walt Stamm.

Sexually transmitted diseases·2024

Area of Science:

  • Gynecology
  • Microbiology
  • Infectious Diseases

Background:

  • Bacterial vaginosis (BV) is a common vaginal condition characterized by an imbalance in microbial flora.
  • It involves a decrease in hydrogen peroxide-producing Lactobacillus species and a significant increase in anaerobic bacteria.
  • BV is linked to adverse health outcomes, including pelvic inflammatory disease, increased HIV susceptibility, and pregnancy complications.

Purpose of the Study:

  • To summarize the current understanding of bacterial vaginosis (BV) etiology and its associated health risks.
  • To highlight the limitations of existing treatments and the urgent need for innovative therapeutic approaches.

Main Methods:

  • Review of existing literature on bacterial vaginosis.
  • Analysis of the microbial spectrum of BV, including newly identified species like Atopobium vaginalis.

Related Experiment Videos

  • Examination of the clinical associations and sequelae of BV.

    • Main Results:

    • BV is a complex polymicrobial syndrome with a distinct microbial profile.
    • Molecular diagnostics have identified novel bacterial species associated with BV.
    • Established antibiotic therapies (metronidazole, clindamycin) are frequently associated with BV recurrence.

    Conclusions:

    • Bacterial vaginosis (BV) poses significant health risks, particularly for women of reproductive age.
    • The high recurrence rate of BV underscores the inadequacy of current treatments.
    • Innovative therapeutic strategies are essential for effective and lasting management of BV.